Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: A case series of five patients

Depression and Anxiety

Volumn 24, Issue 6, 2007, Pages 375-381

  Storch, Eric A ^a   Bagner, Daniel M ^a   Geffken, Gary R ^a   Adkins, Jennifer W ^a   Murphy, Tanya K ^a   Goodman, Wayne K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Cognitive behavioral therapy; Obsessive compulsive disorder; Resistant; Treatment

Indexed keywords

ARIPIPRAZOLE; FLUOXETINE; PAROXETINE; PSYCHOTROPIC AGENT; SERTRALINE;

ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; CHILD; CHILD PSYCHIATRY; CHILDREN'S DEPRESSION INVENTORY; CHILDREN'S YALE BROWN OBSESSIVE COMPULSIVE SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIDIMENSIONAL ANXIETY SCALE FOR CHILDREN; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; SCORING SYSTEM; SELF REPORT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; BEHAVIOR THERAPY; CHILD; CHILD, PRESCHOOL; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DESENSITIZATION, PSYCHOLOGIC; DRUG RESISTANCE; EDUCATION; FEEDING AND EATING DISORDERS OF CHILDHOOD; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY ASSESSMENT; RETREATMENT; SEROTONIN UPTAKE INHIBITORS; TREATMENT FAILURE;

EID: 35348934779     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20260     Document Type: Article

References (43)

1. Abramowitz JS, Foa EB, Franklin ME. 2003. Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. J Consult Clin Psychol 71: 394-398.
2. Abramowitz JS, Whiteside SP, Deacon BJ. 2005. The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behav Ther 36:55-63.
3. Barrett P, Healy-Farrell L, March JS. 2004. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry 43:46-62.
4. Barrett P, Farrell L, Dadds M, Boulter N. 2005. Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: long-term follow-up and predictors of outcome. J Am Acad Child Adolesc Psychiatry 44:1005-1014.
5. Benazon NR, Ager J, Rosenberg DR. 2002. Cognitive behavior therapy in treatment naïve children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther 40:529-539.
6. Cook EH, Wagner KD, March JS, Biederman J, Landau P, Wolkow R, Messig M. 2001. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 40:1175-1189.
7. de Haan E, Hoogduin KAL, Buitelaar JK, Keijsers GPJ. 1998. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 37:1022-1029.
8. DeVeaugh-Geiss J, Moroz G, Biederman J, Cantwell DP. 1992. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: a multicenter trial. J Am Acad Child Adolesc Psychiatry 31:45-49.
9. Douglass HM, Moffitt TE, Dar R, McGee R, Silva P. 1995. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry 34: 1424-1431.
10. Flament MF, Whitaker A, Rapoport JL, Davies M. 1988. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry 27:764-771.
11. Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X. 2005. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 162: 151-161.
12. Franklin ME, Foa EB. 2002. Cognitive behavioral treatments for obsessive compulsive disorder. In: Nathan PE, Gorman JM, editors. A guide to treatments that work, 2nd ed. London: Oxford University Press. p 367-386.
13. Franklin ME, Kozak MJ, Cashman LA, Coles ME, Rheingold A, Foa EB. 1998. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder: an open clinical trial. J Am Acad Child Adolesc Psychiatry 37:412-419.
14. Franklin ME, Tolin DF, March JS, Foa EB. 2001. Treatment of pediatric obsessive-compulsive disorder: a case example of intensive cognitive-behavioral therapy involving exposure and ritual prevention. Cogn Behav Pract 8:297-304.
15. Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D. 2003. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials. J Child Adolesc Psychopharmacol 13S-1:S19-S29.
16. Grabill K, Storch EA, Geffken GR. 2006. Intensive cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. The Behav Therapist (in press).
17. Guy W. 1976. Assessment manual for psychopharmacology, revised (DHEW Publication ABM 76-366). Washington, DC: US Government Printing Office.
18. Kampman M, Keijsers GPJ, Hoogduin CAL. 2002. Addition of cognitive-behaviour therapy for obsessive compulsive disorder patients non-responding to fluoxetine. Acta Psychiatr Scand 106: 314-319.
19. Koran LM, Thienemann ML, Davenport R. 1996. Quality of life for patients with obsessive-compulsive disorder. Am J Psychiatry 153: 783-788.
20. Kovacs M. 1992. The children's depression inventory manual. Toronto: Multi-Health Systems.
21. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ. 1989. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28:566-573.
22. Liebowitz MR, Turner SM, Piacentini J, Beidel DC, Clarvit SR, Davies SO, Graae F, Jaffer M, Lin S-H, Sallee FR, Schmidt AB, Simpson HB. 2002. Flouxetine in children and adolescents with obsessive-compulsive disorder: a placebo controlled trial. J Am Acad Child Adolesc Psychiatry 41:1431-1438.
23. March JS, Mulle K. 1998. OCD in children and adolescents: a cognitive-behavioral treatment manual. New York: Guilford Press.
24. March JS, Mulle K, Herbel B. 1994. Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol driven treatment package. J Am Acad Child Adolesc Psychiatry 33:333-341.
25. March JS, Frances A, Carpenter D. 1997a. The expert consensus guidelines series: treatment of obsessive-compulsive disorder. J Clin Psychiatry 58S:3-72.
26. March JS, Parker JD, Sullivan K, Stallings P, Conners CK. 1997b. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 36:554-565.
27. March JS, Biederman J, Wolkow R, Safferman A, Mardekian J, Cook EH, Cutler NR, Dominguez R, Ferguson J, Muller B, Riesenberg R, Rosenthal M, Sallee FR, Wagner KD. 1998. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA 280:1752-1756.
28. March JS, Sullivan K, Parker JD. 1999. Test-retest reliability of the Multidimensional Anxiety Scale for Children. J Anxiety Disord 13: 349-358.
29. NIMH (National Institute of Mental Health). 1985. Special feature: rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:839-843.
30. Pediatric OCD Team. 2004. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 292:1969-1976.
31. Piacentini J, Berman LR, Jacobs C, McCracken JT, Kretchman J. 2002. Open trial of cognitive behavior therapy for childhood obsessive-compulsive disorder. J Anxiety Disord 16:207-219.
32. Piacentini J, Bergman RL, Keller M, McCracken JT. 2003. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 13S-LS61-S69.
33. Pliszka SR, Browne RG, Olvera RL, Wynne SK. 2000. A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 39:619-626.
34. Riddle MA, Reeve EA, Yaryura-Tobias JA, Yang HM, Claghorn JL, Gaffney G, Greist JH, Holland D, McConville BJ, Pigott T, Walkup JT 2001. Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 40:222-229.
35. Scahill L, Riddle M, McSwiggin-Hardin M, Ort S, King R, Goodman W, Cicchetti D, Leckman J. 1997. Children's Yale-Brown Obsessive-Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852.
36. Simonds LM, Elliot SA. 2001. OCD patients and non-patient groups reporting obsessions and compulsions: phenomenology, help-seeking, and access to treatment. Br J Med Psychol 74:431-449.
37. Simpson HB, Gorfinkle KS, Liebowitz MR. 1999. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial. J Clin Psychiatry 60:584-590.
38. Storch EA. 2005. Pediatric obsessive-compulsive disorder: guide to effective and complete treatment. Contemp Pediatr 22:58-70.
39. Storch EA, Gelfand KM, Geffken GR, Goodman WK. 2003. An intensive outpatient approach to the treatment of obsessive-compulsive disorder: case exemplars. Ann Am Psychother Assoc 4:14-19.
40. Storch EA, Murphy TK, Geffken GR, Soto O, Sajid M, Allen P, Roberti JW, Killiany E, Goodman WK. 2004. Psychometric evaluation of the Children's Yale-Brown Obsessive Compulsive Scale. Psychiatry Res 129:91-98.
41. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P. 2004. Cognitive-behavior therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 65:922-931.
42. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. 2004. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 363:1341-1345.
43. Zohar A. 1999. The epidemiology of obsessive-compulsive disorder in children and adolescents. Child Psychiatry Clin North Am 8: 445-460.